These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
103 related articles for article (PubMed ID: 571128)
1. Acute and chronic morphine effects on plasma corticosteroids and growth hormone in the cat. French ED; Garcia JF; George R Psychoneuroendocrinology; 1978 Oct; 3(3-4):237-44. PubMed ID: 571128 [No Abstract] [Full Text] [Related]
2. Thermoregulatory responses of the unrestrained cat to acute and chronic intravenous administration of low doses of morphine and to naloxone precipitated withdrawal. French ED; Vasquez SA; George R Life Sci; 1978 Jun; 22(21):1947-54. PubMed ID: 566833 [No Abstract] [Full Text] [Related]
3. Tolerance to and physical dependence on morphine: relation to neocortical acetylcholine release in the cat. Labrecque G; Domino EF J Pharmacol Exp Ther; 1974 Oct; 191(1):189-200. PubMed ID: 4473036 [No Abstract] [Full Text] [Related]
4. Self-administration of morphine in the cat. Kilbey MM; Ellinwood EH Int J Addict; 1980 Apr; 15(3):447-60. PubMed ID: 7189749 [TBL] [Abstract][Full Text] [Related]
5. Quantitative properties of plasma corticosterone elevation induced by naloxone-precipitated withdrawal in morphine-dependent rats. Kishioka S; Nishida S; Fukunaga Y; Yamamoto H Jpn J Pharmacol; 1994 Oct; 66(2):257-63. PubMed ID: 7869610 [TBL] [Abstract][Full Text] [Related]
6. Further studies on the acute dependence produced by morphine in opiate naive rats. Eisenberg RM Life Sci; 1982 Oct; 31(15):1531-40. PubMed ID: 6890614 [TBL] [Abstract][Full Text] [Related]
7. Effect of electro-acupuncture on behavioral responses and plasma levels of ACTH and TSH in naloxone-induced morphine withdrawal in rats. Fung KP; Choa GH; Choy YM; Lee CY; Leung KC; Tsang D; Tso WW; Wen HL Am J Chin Med; 1980; 8(1-2):167-9. PubMed ID: 6249114 [TBL] [Abstract][Full Text] [Related]
8. Acute and chronic effects of morphine and withdrawal from morphine on temperature in the cat. French ED; Vasquez SA; George R Proc West Pharmacol Soc; 1976; 19():273-7. PubMed ID: 1033555 [No Abstract] [Full Text] [Related]
9. Behavioral changes produced in the cat by acute and chronic morphine injection and naloxone precipitated withdrawal. French ED; Vasquez SA; George R Eur J Pharmacol; 1979 Aug; 57(4):387-97. PubMed ID: 573695 [TBL] [Abstract][Full Text] [Related]
10. Effects of chronic treatment with diazepam, phenobarbital, or amphetamine on naloxone-precipitated morphine withdrawal. Eisenberg RM Drug Alcohol Depend; 1985 Aug; 15(4):375-81. PubMed ID: 4053975 [TBL] [Abstract][Full Text] [Related]
11. Role of plasma catecholamines in eliciting cardiovascular changes seen during naloxone-precipitated withdrawal in conscious, unrestrained morphine-dependent rats. Chang AP; Dixon WR J Pharmacol Exp Ther; 1990 Sep; 254(3):857-63. PubMed ID: 2395117 [TBL] [Abstract][Full Text] [Related]
12. The effects of intracerebral naloxone on plasma corticosterone and growth hormone levels in morphine dependent rats. Mentzer G; George R; Garcia JF Proc West Pharmacol Soc; 1977; 20():385-8. PubMed ID: 408822 [No Abstract] [Full Text] [Related]
13. Increase in plasma cyclic AMP levels elicited by naloxone in morphine-dependent male mice. Muraki T; Tokunaga Y; Makadate T; Kato R Neuropharmacology; 1981 Feb; 20(2):177-81. PubMed ID: 6259549 [No Abstract] [Full Text] [Related]
14. The effect of naloxone on blood catecholamine levels in conscious unrestrained morphine dependent rats. Dixon WR; Chandra A Proc West Pharmacol Soc; 1987; 30():167-70. PubMed ID: 3628269 [No Abstract] [Full Text] [Related]
15. Potential usefulness of single-dose acute physical dependence on and tolerance to morphine for the evaluation of narcotic antagonists. Jacob JJ; Barthelemy CD; Tremblay EC; Colombel MC Adv Biochem Psychopharmacol; 1973; 8(0):299-318. PubMed ID: 4800176 [No Abstract] [Full Text] [Related]
16. Ethopharmacological analysis of naloxone-precipitated morphine withdrawal syndrome in rats: a newly-developed "etho-score". Fdez Espejo E; Cador M; Stinus L Psychopharmacology (Berl); 1995 Nov; 122(2):122-30. PubMed ID: 8848527 [TBL] [Abstract][Full Text] [Related]
19. Nuclear factor-kappa-B inhibitor modulates the development of opioid dependence in a mouse model of naloxone-induced opioid withdrawal syndrome. Rehni AK; Bhateja P; Singh TG; Singh N Behav Pharmacol; 2008 May; 19(3):265-9. PubMed ID: 18469544 [TBL] [Abstract][Full Text] [Related]
20. Quasi morphine-abstinence syndrome. Collier HO; Francis DL; Henderson G; Schneider C Nature; 1974 May; 249(456):471-3. PubMed ID: 4545823 [No Abstract] [Full Text] [Related] [Next] [New Search]